ArticleMaterials today. Bio2025

A 'two-missile' nanoplatform for targeting triple-negative breast cancer: prodrug activation and immune enhancement.

Haiping Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.